BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19443415)

  • 1. Effects of the conventional antitumor therapies surgery, chemotherapy, radiotherapy and immunotherapy on regulatory T lymphocytes in cancer patients.
    Lissoni P; Brivio F; Fumagalli L; Messina G; Meregalli S; Porro G; Rovelli F; Vigorè L; Tisi E; D'Amico G
    Anticancer Res; 2009 May; 29(5):1847-52. PubMed ID: 19443415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-helper/T-regulator lymphocyte ratio as a new immunobiological index to quantify the anticancer immune status in cancer patients.
    Brivio F; Fumagalli L; Parolini D; Messina G; Rovelli F; Rescaldani R; Vigore L; Vezzo R; Vaghi M; Di Bella S; Lissoni P
    In Vivo; 2008; 22(5):647-50. PubMed ID: 18853761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between psychoncology and psychoneuroendocrinoimmunology (PNEI): enhanced T-regulatory lymphocyte activity in cancer patients with self-punishement, evaluated by Rorschach test.
    Messina G; Lissoni P; Bartolacelli E; Magotti L; Clerici M; Marchiori P; Colombo E
    In Vivo; 2010; 24(1):75-8. PubMed ID: 20133980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T-cells are possible effect prediction markers of immunotherapy for cancer patients.
    Wada J; Yamasaki A; Nagai S; Yanai K; Fuchino K; Kameda C; Tanaka H; Koga K; Nakashima H; Nakamura M; Tanaka M; Katano M; Morisaki T
    Anticancer Res; 2008; 28(4C):2401-8. PubMed ID: 18751426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conventional chemotherapy combined with the repetitive immune cell transfer for patients with refractory advanced gastric cancer].
    Toh U; Fujii T; Mishima M; Imaizumi T; Koga A; Yano S; Shirouzu K; Yahara T; Yamana H
    Gan To Kagaku Ryoho; 2007 Nov; 34(12):1931-3. PubMed ID: 18219856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis.
    Cesana GC; Romano F; Piacentini G; Scotti M; Brenna A; Bovo G; Vaghi M; Aletti G; Caprotti R; Kaufman H; Uggeri F
    Ann Surg Oncol; 2007 Apr; 14(4):1295-304. PubMed ID: 17225981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of surgery-induced decline in circulating dendritic cells by subcutaneous preoperative administration of IL-2 in operable cancer patients.
    Brivio F; Lissoni P; Gilardi R; Ferrante R; Vigore L; Curzi L; Uggeri F; Nespoli A; Fumagalli L
    J Biol Regul Homeost Agents; 2000; 14(3):200-3. PubMed ID: 11037053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells?
    Zhang L; Dermawan KT; Jin ML; Xiong SD; Chu YW
    Med Hypotheses; 2008 Nov; 71(5):802-4. PubMed ID: 18691831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4CD25+ regulatory T cells in patients with advanced gastrointestinal cancer treated with chemotherapy.
    Xu H; Mao Y; Dai Y; Wang Q; Zhang X
    Onkologie; 2009 May; 32(5):246-52. PubMed ID: 19420970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory T cells: potential target in anticancer immunotherapy.
    Juang CM; Hung CF; Yeh JY; Horng HC; Twu NF; Cheng MH; Wen KC; Yuan CC; Chao KC; Wu TC; Yen MS
    Taiwan J Obstet Gynecol; 2007 Sep; 46(3):215-21. PubMed ID: 17962099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.
    Giuntoli RL; Webb TJ; Zoso A; Rogers O; Diaz-Montes TP; Bristow RE; Oelke M
    Anticancer Res; 2009 Aug; 29(8):2875-84. PubMed ID: 19661290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer chemotherapy-induced lymphocytosis: a revolutionary discovery in the medical oncology.
    Lissoni P; Fumagalli L; Brivio F; Rovelli F; Messina G; Di Fede G; Colciago M; Brera G
    J Biol Regul Homeost Agents; 2006; 20(1-2):29-35. PubMed ID: 18088552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of immunoendocrine strategies with pineal indoles and interleukin-2 to prevent radiotherapy-induced lymphocytopenia in cancer patients.
    Lissoni P; Rovelli F; Brivio F; Fumagalli L; Brera G
    In Vivo; 2008; 22(3):397-400. PubMed ID: 18610754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy in patients with less than complete response to chemotherapy.
    Recchia F; Candeloro G; Necozione S; Bisegna R; Bratta M; Rea S
    Anticancer Res; 2009 Feb; 29(2):567-72. PubMed ID: 19331204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgery-induced decline in circulating dendritic cells in operable cancer patients: a possible explanation of postoperative immunosuppression.
    Brivio F; Gilardi R; Bucocev R; Ferrante R; Rescaldani R; Vigoré L; Fumagalli L; Nespoli A; Lissoni P
    Hepatogastroenterology; 2000; 47(35):1337-9. PubMed ID: 11100346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune monitoring of cancer patients undergoing experimental immunotherapy.
    Shankar G; Salgaller ML
    Curr Opin Mol Ther; 2000 Feb; 2(1):66-73. PubMed ID: 11249653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of IL-2 immunotherapy in metastatic renal cell carcinoma in relation to the psychic profile as evaluated using the Rorschach test.
    Messina G; Lissoni P; Bartolacelli E; Fumagalli L; Brivio F; Colombo E; Gardani GS
    Anticancer Res; 2007; 27(4C):2985-8. PubMed ID: 17695482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy-induced lymphocytopenia: changes in total lymphocyte count and in lymphocyte subpopulations under pelvic irradiation in gynecologic neoplasms.
    Lissoni P; Meregalli S; Bonetto E; Mancuso M; Brivio F; Colciago M; Gardani G
    J Biol Regul Homeost Agents; 2005; 19(3-4):153-8. PubMed ID: 16602631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regular tai chi chuan exercise enhances functional mobility and CD4CD25 regulatory T cells.
    Yeh SH; Chuang H; Lin LW; Hsiao CY; Eng HL
    Br J Sports Med; 2006 Mar; 40(3):239-43. PubMed ID: 16505081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
    Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
    Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.